top of page
PUBLICATIONS

The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome

Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF–licensed myeloid cells

Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment

Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth

Eosinophil surface receptor EMR1: a novel therapeutic target for eosinophilic disorders
Mayo Clinic Proceedings
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

CAR-T–cell neurotoxicity: hope is on the horizon
Editorial in Blood Journal
by Omar Ahmed
bottom of page